- Investing Ideas
- Italian Pharmaceuticals & Biotech Pure Equity Growth
Italian Pharmaceuticals & Biotech Pure Equity Growth
Results
2
0 new
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
2 companies
Krystal Biotech
Market Cap: €10.0b
A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.
1KRYS
€308.50
7D
4.6%
1Y
154.5%
Corcept Therapeutics
Market Cap: €8.6b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
1CORT
€70.86
7D
-2.4%
1Y
10.5%